Pure Global

Safety and Performance of the Cardiovalve TR Replacement System - Trial NCT05486832

Access comprehensive clinical trial information for NCT05486832 through Pure Global AI's free database. This phase not specified trial is sponsored by Cardiovalve Ltd. and is currently Recruiting. The study focuses on Tricuspid Regurgitation. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT05486832
Recruiting
Device Trial
device
Trial Details
ClinicalTrials.gov • NCT05486832
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Safety and Performance of the Cardiovalve TR Replacement System
Safety and Performance of the Cardiovalve TR Replacement System for Tricuspid Regurgitation

Study Focus

Tricuspid Regurgitation

Cardiovalve TR valve replacement System

Interventional

device

Sponsor & Location

Cardiovalve Ltd.

Bad Oeynhausen,Berlin,Bonn,Hamburg,Köln,Lübeck,Regensburg, Germany

Timeline & Enrollment

N/A

Aug 15, 2022

Dec 15, 2026

100 participants

Primary Outcome

Freedom from device or procedure-related adverse events,Reduction in TR grade

Summary

The objective of this study is to evaluate the safety and performance of Cardiovalve TR
 system

ICD-10 Classifications

Tricuspid stenosis
Tricuspid stenosis with insufficiency
Nonrheumatic tricuspid (valve) stenosis
Tricuspid insufficiency
Nonrheumatic tricuspid (valve) stenosis with insufficiency

Data Source

ClinicalTrials.gov

NCT05486832

Device Trial